Publikationen, an denen er mitarbeitet Laura San Segundo Payo (4)

2015

  1. The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

    Oncotarget, Vol. 6, Núm. 22, pp. 18875-18890

2010

  1. In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma

    Haematologica, Vol. 95, Núm. 5, pp. 794-803

2009

  1. DNA DSBs Induction by Zalypsis, a Novel Marine Compound, Results in Potent Antimyeloma Activity

    CLINICAL LYMPHOMA & MYELOMA

  2. Zalypsis: A novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks

    Blood, Vol. 113, Núm. 16, pp. 3781-3791